Skip to Content

54 150 (Flecainide Acetate 150 mg)

Pill with imprint 54 150 is White, Capsule-shape and has been identified as Flecainide Acetate 150 mg. It is supplied by Roxane Laboratories, Inc..

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; paroxysmal supraventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 150

Flecainide acetate 150 mg 54 150
Flecainide acetate 150 mg 54 150
Flecainide acetate 150 mg 54 150  Front
Flecainide acetate 150 mg 54 150  Back

Flecainide Acetate

Imprint
54 150
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roxane Laboratories, Inc.
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, croscarmellose sodium, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00054-0012 Roxane Laboratories, Inc.
54868-5586 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "54 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.